What Is MOTS-c? The Mitochondrial Peptide Explained

Researchers have proposed several connected mechanisms, mostly from cell and mouse studies:

• AMPK activation: MOTS-c disrupts part of the folate cycle, which leads to buildup of AICAR, a natural activator of AMPK. AMPK is the cell’s main energy sensor and the same pathway exercise switches on.
• Glucose uptake in muscle: by activating AMPK, MOTS-c increases how much glucose skeletal muscle takes in, improving insulin sensitivity in animal models.
• Stress response in the nucleus: under metabolic stress, MOTS-c can move into the cell nucleus and influence genes involved in antioxidant defense.

Because these effects overlap with what exercise does, MOTS-c is often described as an exercise-mimetic in research literature.

Metabolism and weight. In the original 2015 study, mice fed a high-fat diet and treated with MOTS-c gained less weight and did not develop the insulin resistance seen in untreated mice.

Exercise and aging. A 2021 study in Nature Communications reported that MOTS-c levels in human muscle and blood rise during exercise. In the same paper, older mice given MOTS-c showed better physical performance on treadmill and grip tests.

Human data. Human research is much thinner. Observational studies link lower circulating MOTS-c with obesity, type 2 diabetes and aging, but those links do not prove cause. A modified analog developed by CohBar reached early human trials but was later discontinued. When the FDA reviewed MOTS-c in 2026, it noted cell and animal findings, human physiology research, and a registered clinical trial that had not yet posted results.

There are no large human safety studies of MOTS-c. Animal studies have not reported major toxicity, but that does not establish safety in people. Reports from people using research-grade products describe injection-site reactions, but these are not controlled data. Product quality is a separate concern: research peptides are not made under drug manufacturing standards, which is why third-party testing and certificates of analysis matter.

On July 23, 2026, the FDA’s Pharmacy Compounding Advisory Committee (PCAC) voted 7–5, with two abstentions, to recommend adding MOTS-c to the 503A Bulks List for proposed uses in obesity and osteoporosis. FDA scientific staff had recommended against it.

• The vote is advisory and non-binding.
• MOTS-c is not FDA-approved for any use.
• The FDA must still go through rulemaking before pharmacies can legally compound it, which may take into 2027 or longer.

MOTS-c is often grouped with other compounds described as exercise-mimetics or mitochondrial support. They work through different routes:

MOTS-c vs AICAR. Interestingly, one of the ways MOTS-c is thought to work is by raising the body’s own AICAR levels. AICAR itself has been studied for decades as an AMPK activator, but it is a small molecule, not a peptide.

MOTS-c vs humanin. Both are coded in mitochondrial DNA and both decline with age in some studies. Humanin is studied more for nerve-cell protection, while MOTS-c is studied more for metabolism.

Products sold as MOTS-c by research suppliers are laboratory chemicals, not medicines. They are not made under drug manufacturing rules, so quality varies a lot between vendors. If you are evaluating a MOTS-c supplier for lab research, these are the checks that matter:

• Batch-specific COA: the certificate should match the lot number on your vial, not a generic sample.
• Independent lab: testing should come from a named third-party lab, ideally with a way to verify the report online.
• Identity, not just purity: HPLC purity alone does not confirm the right molecule; look for mass spectrometry (MS) identity confirmation.
• Endotoxin and sterility results: these matter for any injectable research material.
• Correct fill amount: the measured content should be close to the labeled milligrams.

Our Trusted Sources page lists vendors we track, with current community codes. Our guide to reading a certificate of analysis explains each line of a COA.

• MOTS-c is a 16-amino-acid peptide coded by mitochondrial DNA.
• It activates AMPK, the same energy sensor switched on by exercise.
• Mouse studies show better insulin sensitivity and physical performance.
• Controlled human trials are still missing.
• An FDA panel recommended it for compounding in July 2026, but it is not FDA-approved.

What is MOTS-c?

MOTS-c is a 16-amino-acid peptide encoded by mitochondrial DNA. It acts like a hormone that helps regulate metabolism and is studied for insulin sensitivity and exercise capacity.

What does MOTS-c do?

In cell and animal studies, it activates AMPK, increases glucose uptake into muscle and improves insulin sensitivity. Human evidence is limited.

Is MOTS-c an exercise mimetic?

It is often described that way because it activates some of the same pathways as exercise, and its levels rise during exercise. It is not a substitute for exercise.

Is MOTS-c FDA-approved?

No. An FDA advisory committee voted 7–5 in July 2026 to recommend it for the compounding list, but the FDA has not yet acted and it is not an approved drug.

Does MOTS-c help with weight loss in humans?

There are no completed controlled human trials showing weight loss. The weight-related findings come from mouse studies.

• Cell Metabolism – Lee et al. (2015), The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis
• Nature Communications – Reynolds et al. (2021), MOTS-c is an exercise-induced mitochondrial-encoded regulator
• Bass, Berry & Sims – FDA advisory committee recommends six peptides for compounding (2026)
• McDermott Will & Schulte – PCAC backs majority of peptides in two-day public meeting (2026)
• AJMC – FDA panel backs 6 peptides for compounding (2026)